An interventional study of Conventional Physiotherapy and Aerobic Exercise Programme in Intervertebral Disc Displacement, Low Back Pain and Radiculopathy, sponsored by Çankırı Karatekin University. Recruiting at 3 sites in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-08-08.
Sponsored by Çankırı Karatekin University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 121 studies in Intervertebral Disc Displacement with a site in Turkey — 22 open to participants now, 28 under way, none of them phase 3. Intervertebral Disc Displacement · Turkey.
Among the 121 studies in Intervertebral Disc Displacement with a site in Turkey, this one is the 65th largest by planned enrollment of the 86 interventional ones that give a count, is one of 18 that started in 2025, is one of 85 with no phase, reaches primary completion later than 13 of the 27 other live ones, and was the 80th registered.
474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.
Browse Intervertebral Disc Displacement studies →22 of the 121 studies in Intervertebral Disc Displacement with a site in Turkey are open now. Recruiting first, the newest first:
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · Sites in Turkey
Ages 18–75
Istinye University · Sites in Turkey
Ages 18–65
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65
Halil Kalaycı · Sites in Turkey
Ages 22+
Diskapi Teaching and Research Hospital · Sites in Turkey
Ages 18–75
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 48 Intervertebral Disc Displacement studies recruiting now, 20 (42%) set no upper age limit and 24 (50%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
121 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 18 started in 2025.
This study's planned enrollment of 42 is below the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.
Median enrollment 60 across the 86 interventional studies, 88 across the 35 observational. Of the 82 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 121 has an industry lead sponsor. The 10 most frequent:
Çankırı Karatekin University is the lead sponsor of 66 studies on the registry; 19 are open to participants now.
Çankırı Karatekin University has 1 study filed under Intervertebral Disc Displacement — fewer than ten, so there is no comparison to draw.
6 of the studies in Intervertebral Disc Displacement with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07550569Baskent UniversityEffectiveness of High Intensity Laser Therapy in Management of Lumbar Disc Herniation | 2026-11-30 |
| NCT07750418Vezirköprü State HospitalComparison of TLIP Block and QIP Block for Postoperative Analgesia After Lumbar Spine Surgery | 2026-12-31 |
| NCT07862257Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalPulmonary Mechanics and Cerebral Oxygenation During Prone Lumbar Disc Surgery | 2027-01-30 |
| NCT07400068Mersin UniversityPLDD With or Without Transforaminal Epidural Steroid Injection in Lumbar Disc Herniation | 2027-04-01 |
| NCT07768241Fatih Sultan Mehmet Training and Research HospitalLower Back Muscle Size and Recovery After Lumbar Disc Herniation Surgery | 2027-06 |
Add all 6 to your calendar (.ics) → With an account.
Among the 121 studies in Intervertebral Disc Displacement with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
**Brief Summary**
Lumbar radicular pain arising from intervertebral disc herniation is commonly managed with a caudal epidural steroid injection (CESI), a minimally invasive procedure that delivers anti-inflammatory medication to the sacral hiatus. Although CESI affords short-term analgesia, a sizable proportion of patients continue to experience pain-related disability and diminished quality of life, underscoring the need for optimised post-injection rehabilitation.
This single-centre, three-arm, parallel-group randomised controlled trial will evaluate the comparative efficacy of two evidence-informed exercise paradigms-moderate-intensity aerobic training and progressive lumbopelvic stabilisation-when each is superimposed upon a standard physiotherapy package of heat, therapeutic ultrasound and transcutaneous electrical nerve stimulation (TENS). Forty-two adults (18-70 years) with MRI-confirmed lumbar disc herniation who have undergone CESI at Çankırı State Hospital will be randomly allocated (1:1:1) to one of the following six-week interventions, initiated two weeks post-injection and delivered thrice weekly under physiotherapist supervision:
Primary end-points are pain intensity (10 cm Visual Analogue Scale) and back-specific disability (Oswestry Disability Index). Secondary end-points include generic health-related quality of life (SF-12) and lumbar proprioceptive body awareness (Fremantle Back Awareness Questionnaire). Outcomes will be captured at baseline, post-intervention (6 weeks) and at 3- and 6-month follow-up to ascertain both immediate and sustained effects.
Study Question Does adjunctive aerobic or core-stabilisation exercise confer superior reductions in pain and disability, and greater gains in quality of life and body awareness, compared with conventional physiotherapy alone in adults following CESI for lumbar disc herniation?
It is hypothesised that both exercise approaches will yield clinically and statistically superior outcomes relative to standard care, with stabilisation training providing the most durable functional benefits. Findings are expected to refine post-CESI rehabilitation algorithms and inform evidence-based clinical guidance for physiotherapists managing lumbar disc pathology.
Scientific Rationale and Background Caudal epidural steroid injection (CESI) is widely employed to attenuate lumbosacral radicular pain by delivering glucocorticoids into the sacral hiatus, thereby diminishing local biochemical inflammation around the affected nerve roots. While CESI frequently yields rapid analgesia, pain recurrence and activity limitation are common within three to six months, indicating that pharmacological attenuation of inflammation alone is insufficient to restore neuromuscular control and functional capacity. Emerging evidence suggests that structured exercise commenced shortly after CESI can exploit the "analgesic window" to retrain motor patterns, enhance spinal stability, and improve cardiovascular fitness-yet the optimal exercise paradigm remains unclear. Aerobic conditioning may promote anti-inflammatory myokine release and general de-conditioning reversal, whereas lumbopelvic stabilisation targets segmental control deficits and proprioceptive impairment-both recognised contributors to chronicity in lumbar disc pathology.
Study Design and Setting This is a single-centre, prospective, three-arm, parallel-group, superiority randomised controlled trial conducted at the Department of Physiotherapy, Çankırı State Hospital, Türkiye. Allocation (1:1:1) is computer-generated with permuted blocks of variable size; assignments are sealed in sequentially numbered opaque envelopes by an independent statistician to ensure allocation concealment. Outcome assessors and data analysts are blinded to group assignment. Interventions are delivered in a dedicated physiotherapy gymnasium under the supervision of senior musculoskeletal physiotherapists trained in study procedures.
Intervention Logic
Each participant receives a two-week "wash-in" period following CESI to permit stabilisation of acute pharmacodynamic effects. Thereafter, three arms are implemented over six weeks (18 supervised sessions):
Conventional Physiotherapy + Core-Stabilisation Exercise - modality package followed by a phased stabilisation protocol:
Progression criteria include pain ≤3/10 on VAS and flawless technique for ≥10 repetitions; repetitions, load, or surface instability are advanced by \~10 % weekly.
All participants receive a standardised education booklet on spine-sparing strategies and are advised to maintain normal activities.
Sample Size Justification Using an anticipated between-group effect size of d = 1.0 for pain reduction-derived from prior work on CESI-augmented exercise (Cohen's f = 0.5)-42 participants (14 per arm) provide 80 % power (α = 0.05, two-sided) to detect clinically important differences, allowing for 25 % attrition.
Data Management and Statistical Plan Data are entered into REDCap with double-entry verification. The primary analysis follows the intention-to-treat principle, employing linear mixed-effects models with random intercepts for participants, fixed effects for group, time, and their interaction, and baseline score as covariate. Missing data will be handled using restricted maximum likelihood under a missing-at-random assumption; sensitivity analyses will include multiple imputation. Secondary outcomes will be analysed similarly with Bonferroni-adjusted confidence intervals. Effect sizes (Hedges g) and minimal clinically important differences will be reported.
Safety Monitoring Adverse events-including exacerbation of radicular pain, hemodynamic instability during aerobic sessions, or procedure-related complications-are recorded at each visit. An independent physician adjudicates seriousness and relatedness; criteria for withdrawal include VAS ≥ 7 persisting >48 h or cardiovascular red-flags according to American College of Sports Medicine guidelines. A Data Safety Monitoring Sub-committee reviews unblinded safety reports quarterly.
*Knowledge Translation* Results will inform evidence-based guidelines on post-CESI rehabilitation, disseminated via peer-reviewed publication, conference presentation, and integration into continuing professional development modules for physiotherapists. De-identified datasets and analytic code will be deposited in an open repository within 12 months of primary outcome publication, aligning with FAIR data principles and UK Research Councils' open-science policy.
In summary, this rigorously designed trial seeks to delineate whether adjunctive aerobic or motor-control-oriented exercise offers superior and durable benefits over conventional modalities alone in the critical post-injection period for patients with lumbar disc herniation, thereby refining best-practice rehabilitation pathways.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Hepatitis C is a virus that infects the liver. An HCV antibody test can stay positive after an infection has cleared (and is occasionally positive without one); an HCV RNA test shows whether the virus is there now.
After treatment, hepatitis C counts as cured when HCV RNA is still undetectable 12 weeks or more after the treatment ended. Studies often accept people cured this way.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hepatitis C tests
Hepatitis C is a virus that infects the liver. An HCV antibody test can stay positive after an infection has cleared (and is occasionally positive without one); an HCV RNA test shows whether the virus is there now.
After treatment, hepatitis C counts as cured when HCV RNA is still undetectable 12 weeks or more after the treatment ended. Studies often accept people cured this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Conventional Physiotherapy (moist heat, therapeutic ultrasound, TENS)
Other: Conventional Physiotherapy
* Behavioral: Aerobic Exercise (treadmill walking) * Other: Conventional Physiotherapy
Other: Conventional Physiotherapy · Behavioral: Aerobic Exercise Programme
* Behavioral: Core-Stabilisation Exercise * Other: Conventional Physiotherapy
Other: Conventional Physiotherapy · Behavioral: Core-Stabilization Exercise Programme
Standard physical-agent package delivered three times weekly for 6 weeks: 20 min moist hot-pack (≈70 °C hydrocollator packs); 5 min continuous therapeutic ultrasound (1 MHz, 1 W cm-²); 20 min biphasic TENS (100 Hz, 100 µs). Initiated 2 weeks after the caudal epidural steroid injection (CESI).
Supervised treadmill walking three times weekly for 6 weeks: 5 min warm-up at \~40 % HR\<sub\>max\</sub\>; 10-25 min load at 55-80 % HR\<sub\>max\</sub\> (5 % weekly progression); 5 min cool-down. Heart-rate telemetry and Borg CR-10 used to titrate intensity. Starts 2 weeks post-CESI.
Phased lumbopelvic motor-control regimen three times weekly for 6 weeks: Phase I isolated transversus abdominis/multifidus activation with pressure biofeedback; Phase II functional co-contraction with limb movements in quadruped, sitting, standing; Phase III dynamic tasks on Swiss-ball/BOSU with resistance. Progression requires pain ≤ 3/10 VAS and flawless technique. Begins 2 weeks post-CESI.
Change in Pain Intensity (Numeric Rating Scale, 0-10)
Unit of Measure: points on a 0-to-10 scale Description: 11-point Numeric Rating Scale; 0 = no pain, 10 = worst imaginable pain. Change from baseline will be calculated at each follow-up. Higher scores indicate worse pain.
Time frame: Baseline; 6 weeks; 3 months; 6 months
Change in Disability (Oswestry Disability Index, 0-100)
Unit of Measure: percentage points (0-100) Description: Oswestry Disability Index v2.1a; higher scores denote greater disability. Change from baseline will be reported.
Time frame: Baseline, 6 weeks, 3 months, 6 months
Change in Health-Related Quality of Life (SF-12 Physical Component, 0-100)
Unit of Measure: points (0-100) Description: Short-Form-12 v2 Physical Component Summary (PCS); higher scores represent better quality of life.
Time frame: Baseline, 6 weeks, 3 months, 6 months
Change in Health-Related Quality of Life (SF-12 Mental Component, 0-100)
Short-Form-12 v2. Mental Component Summary (MCS) scores; higher values = better QoL. Change from baseline calculated for each follow-up.
Time frame: Baseline; 6 weeks; 3 months; 6 months
Change in Lumbar Body Awareness (Fremantle Back Awareness Questionnaire, 0-36)
Unit of Measure: points (0-36) Description: 9-item FreBAQ; higher scores reflect poorer body perception. Change from baseline reported.
Time frame: Baseline; 6 weeks; 3 months; 6 months
Return-to-Work Days
Unit of Measure: days Description: Self-reported calendar days from CESI to full resumption of habitual occupational duties. Lower values indicate faster return.
Time frame: Up to 6 months
Adverse Events Related to Exercise or CESI
Unit of Measure: number of participants with ≥1 event Description: Musculoskeletal, cardiovascular, or injection-related adverse events, coded per CTCAE v5.0. Both incidence and narrative description will be provided.
Time frame: Throughout 6-week intervention and 6-month follow-up
Not enrolling at this site.
Plan to share: Yes — A de-identified participant-level dataset and accompanying data dictionary will be deposited in an open-access repository (e.g., Open Science Framework) within 12 months of publication of the primary results, accessible to qualified researchers under a CC-BY license.
Started Apr 2025 (actual). Primary completion is estimated for Jan 2026, 8 months after the start.
Of 178 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 8 months is below that.
Counting every sponsor, half of 191 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intervertebral Disc Displacement →
Çankırı Karatekin University